MISSION STATEMENT:

Our Common Goal;

The Greater Well-Being of Humanity.

ANILAB provides consulting services to pharmaceutical companies, contract research laboratories, biomedical equipment companies, and vendors of laboratory animals.

In our profession we are aware of the protocols and procedures that are mandated according to the requirements of the FDA. In the field of Preclinical Safety Evaluation, it is important to consider the ECG findings in determining the eligibility of animals for use on study. In addition, animals on study need to be monitored while evaluating the safety and efficacy of pharmaceutical compounds.

We render ECG and telemetry evaluations, as well as equipment validation.   At ANILAB we can support your ECG evaluation needs following current Good Laboratory Practice (GLP) regulations and Standard Operating Procedures (SOPs).

We invite you to visit the services section of this website so that you can how we can be of benefit to you and your company.

Announcements

ANILAB'S CEO, Dr. Jeffrey Richig, has now been appointed Special Government Employee (SGE) consultant to the FDA for the cardiovascular and renal drugs division. 

Dr. Richig is also an associate member of the Cardiac Safety Research Consortium (CSRC).